NICE new evidence summaries and guidance

NICE has published the first of its evidence summaries of unlicensed/off-label medicines, about the use of tranexamic acid to prevent or treat significant hemorrhage after trauma, an off-label use. The publication of evidence summaries for insulin degludec in Type 1 and 2 diabetes is expected later this autumn, under new medicines evidence summaries.

NICE has also just published guidance on Crohn’s disease in adults, children and young people, and on headaches in young people and adults. The headache guidance highlights the importance of correct diagnosis in deciding on the most appropriate treatment and also urges healthcare professionals to consider the possibility of medication overuse headaches, a “vicious cycle”, according to the GP who chaired the development of the guideline.